United States · FDA National Drug Code directory

Lisinopril and Hydrochlorothiazide

A source-listed medicine record.

Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.

Medicine identity

Source reference
63629-3739_ad77d63b-f36c-4802-9ca3-6a02ef58b9da
Product NDC
63629-3739
Form
TABLET
Composition / generic term
Lisinopril and Hydrochlorothiazide
Labeler
Bryant Ranch Prepack
Marketing category
ANDA
Marketing start / end (source format)
20061004
Source listing expiry
20271231

Source-listed ingredients

  • HYDROCHLOROTHIAZIDE — 25 mg/1
  • LISINOPRIL — 20 mg/1

These values do not establish equivalence or a dose recommendation.

Packages

  • 30 TABLET in 1 BOTTLE (63629-3739-1) · 63629-3739-1
  • 60 TABLET in 1 BOTTLE (63629-3739-2) · 63629-3739-2
  • 90 TABLET in 1 BOTTLE (63629-3739-3) · 63629-3739-3
  • 120 TABLET in 1 BOTTLE (63629-3739-4) · 63629-3739-4
  • 100 TABLET in 1 BOTTLE (63629-3739-5) · 63629-3739-5
  • 180 TABLET in 1 BOTTLE (63629-3739-6) · 63629-3739-6

Source and coverage

Open FDA National Drug Code directory

Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.

Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.

Browse United States records →